Johnson & Johnson JOHNSON & JOHNSON ORD (CDI)
Johnson & Johnson JOHNSON & JOHNS.../ US4781601046 /
0R34
|
- -
|
Chg.
-
|
Volume |
Bid- |
Demandez à- |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
-USD
|
-
|
-
Chiffrre d'affaires: - |
-Bid taille: - |
-Ask la taille: - |
353.05 Mrd.USD |
3.21% |
10.56 |
Description de l'entreprise
Johnson & Johnson and its subsidiaries (the "Company") have employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 250 operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.
Conseil d'administration & Conseil de surveillance
| PDG |
| Joaquin Duato |
| Conseil d'administration |
| Joseph Wolk, Dr. Peter M. Fasolo, Dr. William N. Hait, James Swanson, Jennifer Taubert, Kathryn E. Wengel, Vanessa Broadhurst, John C. Reed, M.D., Ph.D., Liz Forminard, Tim Schmid |
| Conseil de surveillance |
| Joaquin Duato, A. Eugene Washington, M.D., Anne M. Mulcahy, D. Scott Davis, Darius Adamczyk, Dr. Jennifer A. Doudna, Dr. Mary Beckerle, Dr. Nadja West, Hubert Joly, Marillyn A. Hewson, Mark A. Weinberger, Mark B. McClellan, Paula A. Johnson, M.D. |
Données de l'entreprise
| Nom: |
Johnson & Johnson |
| Adresse: |
One Johnson & Johnson Plaza,,New Brunswick, New Jersey 08933, USA |
| Téléphone: |
+1-732-524-0400 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
www.jnj.com |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
77.97% |
| IPO date: |
24/09/1944 |
Calendrier de l'entreprise
|
CW 8 | 18/02/2025
Record Date
|
|
CW 8 | 18/02/2025
Ex-Dividend
|
|
CW 10 | 04/03/2025
Dividend Payment
|
|
CW 16 | 15/04/2025
Interim Report 1st Quarter/3 Months
|